A phase one clinical trial in Philadelphia at Temple University’s Fox Chase Cancer Center is combining two FDA-approved medications, giving new hope for people with an advanced kind of blood cancer.
The trial is designed to help patients with myelofibrosis who aren’t responding to traditional therapies.
Demetria Mears, from Dover, Delaware, has the rare blood cancer, but she’s all smiles checking in with her doctor at Temple Health’s Fox Chase Cancer Center…